Atlas Trials

Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular Analysis

Clinical trial NCT04755023 · COMPLETED

Trial details

NCT number
NCT04755023
Sponsor
Assistance Publique Hopitaux De Marseille
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Oligodendroglioma; Oligoastrocytoma
Start date
2005-12-21
Primary completion
2009-03-15
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.